Company Search:
Advanced Search
Sponsored Links
Orion Oyj Company Snapshot
Orion Oyj operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orion Oyj with three other pharmaceutical manufacturers in Europe: Indivior Plc of the United Kingdom (2018 sales of £755.36 million [US$980.98 million] of which 100% was Buprenorphine Based Drugs), Swedish Orphan Biovitrum AB (publ) of Sweden (9.14 billion Swedish Kronor [US$981.97 million] of which 100% was Sales of Pharmaceuticals), and Alkermes Plc which is based in Ireland (928.72 million Euro [US$1.05 billion] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2018, sales at Orion Oyj were 977.50 million Euro (US$1.10 billion). This is a decrease of 9.9% versus 2017, when the company's sales were 1.08 billion Euro. The sales level in 2018 was fairly close to the level five years ago: in 2013, Orion Oyj had sales of 1.01 billion Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Orion Oyj
  Stock Performance Chart for Orion Oyj
  Stock Data: Recent Stock Performance:
  Current Price (4/18/2019): 30.86
(Figures in Euro)
1 Week -5.3%   13 Weeks -11.6%  
4 Weeks -1.2%   52 Weeks 19.5%  
Orion Oyj Key Data:
  Ticker: ORNBV Country: Finland
  Exchanges: HEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 977,500,000
(Year Ending Jan 2019).
Employees: 3,154
  Currency: Euro Market Cap: 4,341,859,674
  Fiscal Yr Ends: December Shares Outstanding: 140,695,388
  Share Type: B Osake Closely Held Shares: 17,264,729
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.